{"id":"W2341658168","doi":"10.1016/j.jaci.2015.12.670","title":"A Phase 1 First-in-Human Study (B4901001) Evaluating a Novel Anti-IgE Vaccine in Adult Subjects with Allergic Rhinitis","year":2016,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institut de Recherche et de Développement en Agroenvironnement; Pfizer (Canada); Ottawa Allergy Research Corporation","funders":"","keywords":"Medicine; Immunoglobulin E; Omalizumab; Immunology; Immunogenicity; Tolerability; Antigen; Allergy; Adjuvant; Adverse effect; Antibody; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002802227,0.001509449,0.002236033,0.0003732307,0.0007737855,0.001048124,0.0009402771,0.002101461,0.004120161],"category_scores_gemma":[0.001056674,0.0006211507,0.00162414,0.0002664578,0.00137881,0.001125878,0.0003990991,0.003582067,0.001024388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000785667,"about_ca_system_score_gemma":0.002167226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00207625,"about_ca_topic_score_gemma":0.004094155,"domain_scores_codex":[0.9991564,0.0004392687,0.00003430291,0.0001142635,0.00005512478,0.0002006448],"domain_scores_gemma":[0.9991309,0.0001850517,0.00009271617,0.00009242819,0.00007211878,0.0004267658],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5496592,0.2256696,0.01314098,0.0009954924,0.001498416,0.0008626763,0.0004838174,0.001878646,0.09769968,0.0003607911,0.005639919,0.1021108],"study_design_scores_gemma":[0.1824924,0.8004156,0.01038049,0.00003118074,0.0003531363,0.0002598015,0.00008633665,0.0003559377,0.00337711,0.0001264301,0.002101446,0.00002012331],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896647,0.001749424,0.001114037,0.0007220674,0.0002849039,0.003720005,0.001371388,0.00009905861,0.001274449],"genre_scores_gemma":[0.9821427,0.002459746,0.002848125,0.002829516,0.0004796204,0.003529661,0.002443439,0.00004608757,0.003221137],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004120161,"threshold_uncertainty_score":0.01481974,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04211529500310938,"score_gpt":0.3661663845066192,"score_spread":0.3240510895035098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}